2265 Capecitabine, oxaliplatin and irinotecan (COI regimen) as perioperative treatment of resectable gastric or gastroesophafageal junction (GEJ) cancer. (September 2015) - Berenato, R.; Pellegrinelli, A.; Pietrantonio, F.; Niger, M.; Caporale, M.; De Braud, F.; Ricchini, F.; Maggi, C.; Di Bartolomeo, M.